← back to search

Gilles Van Cutsem

University of Cape Town · ZA
🔎 Find collaborators in Infectious Diseases · Economics and Econometrics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Infectious Diseases · Economics and Econometrics
Research interest
Research focused on Antiretroviral therapy and Human immunodeficiency virus (HIV), with related work in Tuberculosis, Hazard ratio, Cohort. Notable publications include 'Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial', 'Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa', and 'Community-Based Interventions to Improve and Sustain Antiretroviral Therapy Adherence, Retention in HIV Care and Clinical Outcomes in Low- and Middle-Income Countries for...'.
h-index
citations
1,122
works
11
NIH funding
primary concept
email

Recent publications

Ending deaths from HIV-related cryptococcal meningitis by 2030
The Lancet Infectious Diseases 2020cited by 28position: lastdoi
Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update
Southern African Journal of HIV Medicine 2019cited by 80position: middledoi
South African HIV self-testing policy and guidance considerations
Southern African Journal of HIV Medicine 2017cited by 52position: middledoi
Community-Based Interventions to Improve and Sustain Antiretroviral Therapy Adherence, Retention in HIV Care and Clinical Outcomes in Low- and Middle-Income Countries for Achieving the UNAIDS 90-90-90 Targets
Current HIV/AIDS Reports 2016cited by 185position: middledoi
Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy
Journal of the International AIDS Society 2015cited by 13position: lastdoi
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
The Lancet 2014cited by 259position: middledoi
Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa
PLoS ONE 2013cited by 209position: middledoi
Impact on ART initiation of point‐of‐care CD4 testing at HIV diagnosis among HIV‐positive youth in Khayelitsha, South Africa
Journal of the International AIDS Society 2013cited by 56position: lastdoi
Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study
PLoS ONE 2013cited by 49position: middledoi
Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa
JAIDS Journal of Acquired Immune Deficiency Syndromes 2012cited by 140position: middledoi
Effect of Antiretroviral Therapy on the Diagnostic Accuracy of Symptom Screening for Intensified Tuberculosis Case Finding in a South African HIV Clinic
Clinical Infectious Diseases 2012cited by 51position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew Boulle · University of Cape Town5 papers (2012–2014)Eric Goemaere · University of Cape Town3 papers (2013–2015)Shaheed Mathee · University of Cape Town3 papers (2012–2014)Mhairi Maskew · University of the Witwatersrand2 papers (2012–2013)Judith R. Glynn · London School of Hygiene & Tropical Medicine2 papers (2012–2014)Robert J. Wilkinson · South African Medical Research Council2 papers (2012–2014)Amir Shroufi · Financial Services Authority2 papers (2017–2020)Katherine Hilderbrand · University of Cape Town2 papers (2013–2015)Gary Maartens · South African Medical Research Council2 papers (2012–2014)Molebogeng X. Rangaka · London School of Hygiene & Tropical Medicine2 papers (2012–2014)René Goliath · University of Cape Town2 papers (2012–2014)Matthew P. Fox · Boston University2 papers (2012–2013)Nathan Ford · World Health Organization - Pakistan2 papers (2013–2016)Matthias Egger · Ludwig-Maximilians-Universität München2 papers (2012–2013)Michael Schomaker · University of Cape Town2 papers (2013–2015)Miguel A. Hernán · Harvard University2 papers (2012–2013) · 1 papers (2020–2020)Mauro Schechter · Universidade Federal do Estado do Rio de Janeiro1 papers (2016–2016) · 1 papers (2017–2017) · 1 papers (2013–2013)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Infectious Diseases · Economics and Econometrics →